Showing results (121-130 of 398) with videos related to
Sort By:
Pageof 40
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|February 28, 2012
High-efficiency microstructured semiconductor neutron detectors that are arrayed, dual-integrated, and stackedSteven L Bellinger, Ryan G Fronk, Timothy J Sobering, et al.Brain Research Bulletin|July 13, 2011
MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635Glenn E Hunt, Iain S McGregor, Jennifer L Cornish, et al.Drug and Alcohol Review|February 16, 2022
Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical conditionLlewellyn Mills, Nicholas Lintzeris, Michael O'Malley, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 28, 2008
Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed ratsMurray R Thompson, Paul D Callaghan, Glenn E Hunt, et al.Brain, Behavior, and Immunity|March 11, 2014
The pro-inflammatory cytokine interferon-gamma is an important driver of neuropathology and behavioural sequelae in experimental pneumococcal meningitisL K Too, Helen J Ball, Iain S McGregor, et al.Neuroscience|February 10, 2007
High ambient temperature increases 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")-induced Fos expression in a region-specific mannerG A Hargreaves, G E Hunt, J L Cornish, et al.Drug and Alcohol Review|March 17, 2007
MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical researchKelly J Clemens, Iain S McGregor, Glenn E Hunt, et al.Journal of Psychopharmacology (Oxford, England)|January 26, 2013
A brief history of oxytocin and its role in modulating psychostimulant effectsDean S Carson, Adam J Guastella, Emily R Taylor, et al.Neuropharmacology|January 22, 2018
The role of the vasopressin V1A receptor in oxytocin modulation of methamphetamine primed reinstatementNicholas A Everett, Iain S McGregor, Sarah J Baracz, et al.Clinical Pharmacology and Therapeutics|March 18, 2015
Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawalD J Allsop, N Lintzeris, J Copeland, et al.Pageof 40